For over 10 years, The World Drug Safety Congress Americas has served as the only commercially focused event for the pharmacovigilance community.
In 2019, we are proud to be the only event to gather over 50 Global Heads of Safety and Pharmacovigilance, as well as 150+ other speakers from the leading pharmaceutical companies and emerging biotechs.
The discussions will center on the advancement of next generation technology and the data that has contributed to automating and improving PV methodologies, resulting in improved safety for patients. As we expand the discussions further, the 2019 edition will be featuring a predictive safety track with hundreds of toxicology, non-clinical safety executives discussing toxicity measurement & data, translational safety, predictive models and trial design. In addition to that, our new medical device program will bring into perspective pharmacovigilance and safety approaches in apps, diagnostics, and combination products.
Our Global Pharmacovigilance track will help the industry assess the challenges and opportunities of setting a PV operation abroad, with perspectives from pharma and regulatory authorities from around the world.
The 2019 event will also feature a new venue to accommodate the rapid growth we had this past year.
Join hundreds of the leading stakeholders in the drug safety industry as we gather on April 15-17th at the Pennsylvania Convention Center.
See you in Philadelphia this April!